|
1. Biologie
|
|
|
Working Toward Greater Precision in Childhood Cancers [NIH Director's Blog]
|
|
|
|
|
|
Overall
the studies confirm that childhood cancers often carry many fewer
mutations than adult cancers. Many of the driver genes also appear to be
involved in causing one specific type of childhood cancer. That’s
different than adult cancers, in which mutations in particular genes
often drive multiple forms of cancer.
|
|
|
|
|
|
|
2. Etiologie
|
|
|
Half of Britons mistakenly believe stress causes cancer [The Guardian]
|
|
|
|
|
|
The
WCRF’s latest snapshot of levels of British people’s knowledge about
possible carcinogens also reveals that 51% do not know that processed
meat increases cancer risk. This is despite extensive publicity in
recent years given to evidence linking ham, bacon and other similar
products to raised cancer risk.
|
|
|
|
|
|
|
3.2 Prévention - Obésité
|
|
|
Food industry told to cut calories to tackle obesity [Cancer Research UK]
|
|
|
|
|
|
Alison
Cox, Cancer Research UK’s director of cancer prevention, welcomed the
move and said it’s vital that the government continues to put pressure
on the food industry. “Scientific evidence shows that being overweight
or obese is the UK’s biggest preventable cause of cancer after smoking,
and is linked to 13 different types of the disease,” said Cox.
|
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
A Major Milestone in Consumer Health Empowerment [23andMe]
|
|
|
|
|
|
Results
should be confirmed with a healthcare provider in a clinical setting
before taking any medical action. 23andMe’s BRCA1/BRCA2 report is not
going to be helpful for everyone, but it’s a step in the right
direction. We already know of customers who benefited from this
information.
|
|
|
|
|
|
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
All Cancer Patients Should Have Access To Genomic Testing [Forbes]
|
|
|
|
|
|
Should
insurers pay for these tests, if these serve research purposes? Should
the government? Need philanthropy take care of it? Perhaps Foundation
Medicine needs cut its price, as should other precision oncology
companies (see below) as their tests move forward in the FDA regulatory
pathway.
|
|
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
|
|
5.12.7 Immunothérapies - vaccins
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.6 ESMO
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
|
6.3 Associations/Fondations
|
|
|
|
6.6 Publications
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
6.9 Controverses
|
|
|